These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Brain tumor enhancement in magnetic resonance imaging at 3 tesla: intraindividual comparison of two high relaxivity macromolecular contrast media with a standard extracellular gd-chelate in a rat brain tumor model. Fries P; Runge VM; Bücker A; Schürholz H; Reith W; Robert P; Jackson C; Lanz T; Schneider G Invest Radiol; 2009 Apr; 44(4):200-6. PubMed ID: 19300099 [TBL] [Abstract][Full Text] [Related]
25. Innovative Design of Ca-Sensitive Paramagnetic Liposomes Results in an Unprecedented Increase in Longitudinal Relaxivity. Garello F; Vibhute S; Gündüz S; Logothetis NK; Terreno E; Angelovski G Biomacromolecules; 2016 Apr; 17(4):1303-11. PubMed ID: 26956911 [TBL] [Abstract][Full Text] [Related]
26. Calix[4]arenes as molecular platforms for magnetic resonance imaging (MRI) contrast agents. Schühle DT; Schatz J; Laurent S; Vander Elst L; Muller RN; Stuart MC; Peters JA Chemistry; 2009; 15(13):3290-6. PubMed ID: 19206118 [TBL] [Abstract][Full Text] [Related]
27. Equilibrium and NMR relaxometric studies on the s-triazine-based heptadentate ligand PTDITA showing high selectivity for Gd3+ ions. Baranyai Z; Tei L; Giovenzana GB; Kálmán FK; Botta M Inorg Chem; 2012 Feb; 51(4):2597-607. PubMed ID: 22313334 [TBL] [Abstract][Full Text] [Related]
28. A gadolinium(III) complex with 8-amidequinoline based ligand as copper(II) ion responsive contrast agent. Li WS; Luo J; Chen ZN Dalton Trans; 2011 Jan; 40(2):484-8. PubMed ID: 21113542 [TBL] [Abstract][Full Text] [Related]
29. GdIII complexes with fast water exchange and high thermodynamic stability: potential building blocks for high-relaxivity MRI contrast agents. Laus S; Ruloff R; Tóth E; Merbach AE Chemistry; 2003 Aug; 9(15):3555-66. PubMed ID: 12898682 [TBL] [Abstract][Full Text] [Related]
30. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement. Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417 [TBL] [Abstract][Full Text] [Related]
31. The gadolinium(III)-water hydrogen distance in MRI contrast agents. Caravan P; Astashkin AV; Raitsimring AM Inorg Chem; 2003 Jun; 42(13):3972-4. PubMed ID: 12817950 [TBL] [Abstract][Full Text] [Related]
32. Tris(pyrone) chelates of Gd(III) as high solubility MRI-CA. Puerta DT; Botta M; Jocher CJ; Werner EJ; Avedano S; Raymond KN; Cohen SM J Am Chem Soc; 2006 Feb; 128(7):2222-3. PubMed ID: 16478170 [TBL] [Abstract][Full Text] [Related]
33. Mn2+ complexes with 12-membered pyridine based macrocycles bearing carboxylate or phosphonate pendant arm: crystallographic, thermodynamic, kinetic, redox, and 1H/17O relaxation studies. Drahoš B; Kotek J; Císařová I; Hermann P; Helm L; Lukeš I; Tóth É Inorg Chem; 2011 Dec; 50(24):12785-801. PubMed ID: 22092039 [TBL] [Abstract][Full Text] [Related]
34. An intravascular MRI contrast agent based on Gd(DO3A-Lys) for tumor angiography. Yang CT; Chandrasekharan P; He T; Poh Z; Raju A; Chuang KH; Robins EG Biomaterials; 2014 Jan; 35(1):327-36. PubMed ID: 24138829 [TBL] [Abstract][Full Text] [Related]
35. MD simulations of acyclic and macrocyclic Gd3+-based MRI contrast agents: influence of the internal mobility on water proton relaxivity. Yerly F; Borel A; Helm L; Merbach AE Chemistry; 2003 Nov; 9(22):5468-80. PubMed ID: 14639630 [TBL] [Abstract][Full Text] [Related]
36. A benzene-core trinuclear GdIII complex: towards the optimization of relaxivity for MRI contrast agent applications at high magnetic field. Livramento JB; Helm L; Sour A; O'Neil C; Merbach AE; Tóth E Dalton Trans; 2008 Mar; (9):1195-202. PubMed ID: 18283380 [TBL] [Abstract][Full Text] [Related]
37. Mechanistic studies of a calcium-dependent MRI contrast agent. Li WH; Parigi G; Fragai M; Luchinat C; Meade TJ Inorg Chem; 2002 Jul; 41(15):4018-24. PubMed ID: 12132928 [TBL] [Abstract][Full Text] [Related]
38. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review. Idée JM; Port M; Raynal I; Schaefer M; Le Greneur S; Corot C Fundam Clin Pharmacol; 2006 Dec; 20(6):563-76. PubMed ID: 17109649 [TBL] [Abstract][Full Text] [Related]
39. Pushing the sensitivity envelope of lanthanide-based magnetic resonance imaging (MRI) contrast agents for molecular imaging applications. Aime S; Castelli DD; Crich SG; Gianolio E; Terreno E Acc Chem Res; 2009 Jul; 42(7):822-31. PubMed ID: 19534516 [TBL] [Abstract][Full Text] [Related]
40. Hyperfine coupling constants on inner-sphere water molecules of a triazacyclononane-based Mn(II) complex and related systems relevant as MRI contrast agents. Patinec V; Rolla GA; Botta M; Tripier R; Esteban-Gómez D; Platas-Iglesias C Inorg Chem; 2013 Oct; 52(19):11173-84. PubMed ID: 24070368 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]